Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30
(-1.91%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy's Lab re-launches Buprenorphine and Naloxone Sublingual Film
>>
Dr. Reddy's Lab gets EIR for formulations facility in Visakhapatnam
>>
Dr. Reddy's launches Tadalafil tablets in US market
>>
United Healthcare Services files complaint against Dr Reddy's US subsidiary
>>
Dr. Reddy's Laboratories’ arm continues to recall Levetiracetam Injection from US market
>>
Dr.Reddys Laboratories informs about financial statements
>>
Dr. Reddys Laboratories reports 65% rise in Q3 consolidated net profit
>>
USFDA completes audit at Dr. Reddy's API manufacturing plant
>>
Dr Reddy’s Laboratories informs about press release
>>
Dr. Reddy's Lab, Promius Pharma receive USFDA’s approval for TOSYMRA
<<
<
71
72
73
...143
>
>>